يعرض 1 - 18 نتائج من 18 نتيجة بحث عن '"Moreno-Martínez, D"', وقت الاستعلام: 0.46s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    Academic Journal

    المصدر: Molecular Genetics and Metabolism , 132 (4) pp. 234-243. (2021)

    وصف الملف: text

    Relation: https://discovery.ucl.ac.uk/id/eprint/10120625/3/Moreno%20Marti%CC%81nez_Standardising%20clinical%20outcomes%20measures%20for%20adult%20clinical%20trials%20in%20Fabry%20Disease-%20A%20global%20Delphi%20Consensus_AAM.pdf; https://discovery.ucl.ac.uk/id/eprint/10120625/

    الاتاحة: https://discovery.ucl.ac.uk/id/eprint/10120625/3/Moreno%20Marti%CC%81nez_Standardising%20clinical%20outcomes%20measures%20for%20adult%20clinical%20trials%20in%20Fabry%20Disease-%20A%20global%20Delphi%20Consensus_AAM.pdf
    https://discovery.ucl.ac.uk/id/eprint/10120625/

  4. 4
    Academic Journal

    المصدر: Moreno-Martinez , D , Aguiar , P , Auray-Blais , C , Beck , M , Bichet , D G , Burlina , A , Cole , D , Elliott , P , Feldt-Rasmussen , U , Feriozzi , S , Fletcher , J , Giugliani , R , Jovanovic , A , Kampmann , C , Langeveld , M , Lidove , O , Linhart , A , Mauer , M , Moon , J C , Muir , A , Nowak , A , Oliveira , J P , Ortiz , A , Pintos-Morell , G , ....

    وصف الملف: application/pdf

  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal

    المصدر: McCarthy , E , Moreno Martinez , D , Wilkinson , FL , McHugh , N J , Bruce , I , Pauling , J D , Alexander , M Y & Parker , B 2017 , ' Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of Connective Tissue Disease ' , BBA Clinical , vol. 7 , pp. 16-22 . https://doi.org/10.1016/j.bbacli.2016.11.003

  9. 9
    Academic Journal

    وصف الملف: text

    Relation: https://e-space.mmu.ac.uk/619171/; http://www.fasebj.org/; https://e-space.mmu.ac.uk/619171/1/fj.201601244rr.pdf; Mahmoud, AM , Wilkinson, FL , McCarthy, EM , Moreno-Martinez, D , Langford-Smith, A , Romero, M , Duarte, J and Alexander, MY (2017) Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 31 (10). pp. 4636-4648. ISSN 0892-6638

  10. 10
    Academic Journal

    وصف الملف: text

    Relation: https://e-space.mmu.ac.uk/617637/; http://www.sciencedirect.com/science/journal/22146474; https://e-space.mmu.ac.uk/617637/1/Eoghan%20MPs%20in%20CTD.pdf; McCarthy, EM , Moreno-Martinez, D , Wilkinson, FL , McHugh, NJ , Bruce, IN , Pauling, JD , Alexander, Y and Parker, B (2017) Microparticle subpopulations are potential markers of disease progression and vascular dysfunction across a spectrum of connective tissue disease. BBA Clinical, 7. pp. 16-22. ISSN 2214-6474

  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal
  16. 16
    Periodical

    المصدر: Revista Española de Anestesiología y Reanimación; 20210101, Issue: Preprints

  17. 17
    Academic Journal

    المساهمون: Institut Català de la Salut, Carnicer-Cáceres C, Arranz-Amo JA, Cea-Arestin C Laboratori d'Errors Innats del Metabolisme, Laboratoris Clínics, Vall d’Hebron Hospital, Barcelona, Spain. Camprodon-Gomez M Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Moreno-Martinez D Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Lysosomal Storage Disorders Unit, Royal Free Hospital NHS Foundation Trust and University College London, London WC1E 6BT, UK. Lucas-Del-Pozo S Laboratori de Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK. Moltó-Abad M Validació Funcional i Investigació Preclínica, Distribució de Fàrmacs i Grup d'Orientació, CIBIM-Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08035 Barcelona, Spain. Tigri-Santiña A Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Agraz-Pamplona I Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Rodriguez-Palomares JF Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Hernández-Vara J, Armengol-Bellapart M Laboratori de Malalties Neurodegeneratives, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Del-Toro-Riera M Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Neurologia Pediàtrica, Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Pintos-Morell G Unitat de Malalties Metabòliques Hereditàries, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Validació Funcional i Investigació Preclínica, Distribució de Fàrmacs i Grup d'Orientació, CIBIM-Nanomedicina, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Journal of Clinical Medicine;10(8); https://doi.org/10.3390/jcm10081664; Carnicer-Cáceres C, Arranz-Amo JA, Cea-Arestin C, Camprodon-Gomez M, Moreno-Martinez D, Lucas-Del-Pozo S, et al. Biomarkers in Fabry Disease: Implications for Clinical Diagnosis and Follow-up. J Clin Med. 2021 Apr 13;10(8):1664.; https://hdl.handle.net/11351/6740; 000644476500001

  18. 18

    المساهمون: Institut Català de la Salut, [Quijada-Fraile P, Martín-Hernández E] Unidad de Enfermedades Mitocondriales y Enfermedades Metabólicas Hereditarias, Servicio de Pediatría, Hospital Universitario 12 de Octubre, CSUR Enfermedades Metabólicas, MetabERN, Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), CIBERER, Madrid, Spain. [Arranz Canales E] Servicio de Medicina Interna, CSUR Enfermedades Metabólicas, MetabERN, Instituto de Investigación Sanitaria Hospital 12 de octubre (imas12), Hospital Universitario 12 de Octubre, Madrid, Spain. [Ballesta-Martínez MJ, Guillén-Navarro E] Sección de Genética Médica, Hospital Clínico Universitario Virgen de la Arrixaca, IMIB Arrixaca, Universidad de Murcia, Murcia, Spain. CIBERER-ISCIII, Madrid, Spain. [Pintos-Morell G, Moltó-Abad M] Divisió de Malalties Minoritàries, Centre de Referència de Trastorns Metabòlics Hereditaris, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Moreno-Martínez D] Divisió de Malalties Minoritàries, Centre de Referència de Trastorns Metabòlics Hereditaris, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Lysosomal Storage Disorders Unit, The Royal Free Hospital NHS Foundation Trust and University College London, London, UK, Vall d'Hebron Barcelona Hospital Campus

    المصدر: ORPHANET JOURNAL OF RARE DISEASES
    r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
    instname
    Orphanet Journal of Rare Diseases
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-9 (2021)
    Scientia

    مصطلحات موضوعية: Adult, Ligamentous laxity, medicine.medical_specialty, Health-related quality of life, Mucopolysaccharidosis, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Hip dysplasia (canine), Young Adult, chemistry.chemical_compound, Elosulfase alfa, Quality of life, Interquartile range, Internal medicine, medicine, Hip Dislocation, Humans, Enzyme Replacement Therapy, Pharmacology (medical), Malalties rares - Tractament, Mucopolysaccharidosis IVA, Elosulfase alfa, Health-related quality of life, Mobility, Morquio A syndrome, Mucopolysaccharidosis IVA, terapéutica::farmacoterapia::terapia enzimática::tratamiento de sustitución enzimática [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Genetics (clinical), ambiente y salud pública::salud pública::medidas epidemiológicas::demografía::estado de salud::calidad de vida [ATENCIÓN DE SALUD], Mobility, business.industry, Research, Enzims - Ús terapèutic, Mucopolysaccharidosis IV, General Medicine, Enzyme replacement therapy, medicine.disease, Self Care, Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Health Status::Quality of Life [HEALTH CARE], Metabolisme, Errors congènits del - Tractament, enfermedades nutricionales y metabólicas::enfermedades metabólicas::alteraciones congénitas del metabolismo::trastornos congénitos del metabolismo de los carbohidratos::mucopolisacaridosis::enfermedades nutricionales y metabólicas::enfermedades metabólicas::alteraciones congénitas del metabolismo::mucopolisacaridosis IV [ENFERMEDADES], chemistry, Dysplasia, Quality of Life, Medicine, Nutritional and Metabolic Diseases::Metabolic Diseases::Metabolism, Inborn Errors::Carbohydrate Metabolism, Inborn Errors::Mucopolysaccharidoses::Nutritional and Metabolic Diseases::Metabolic Diseases::Metabolism, Inborn Errors::Mucopolysaccharidosis IV [DISEASES], sense organs, business, Morquio A syndrome, Therapeutics::Drug Therapy::Enzyme Therapy::Enzyme Replacement Therapy [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT]

    وصف الملف: application/pdf